Skip to main content
Clinical Trials/EUCTR2007-006234-34-GB
EUCTR2007-006234-34-GBActive, not recruitingNot Applicable

3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: endothelial and endothelial progenitor cell function in men - Simvastatin and endothelial function in men

niversity of Leeds0 sitesStarted: July 15, 2008Last updated:
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Male

Inclusion Criteria

  • We will recruit sedentary
  • * Age 18 to 40 years
  • * Body mass index <30 kg/m2
  • * Normotensive
  • * Non-diabetic
  • * Non-smokers
  • * Normal liver function, haematology and cholesterol.
  • Healthy subjects will be identified by taking a medical history at the preliminary visit by a medically qualified researcher.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • * Female gender
  • * Age <18 or >40 years
  • * Hypertension
  • * Diabetes mellitus
  • * Current smokers
  • * Liver disease (including abnormal liver function tests and / or a history of liver disease)
  • * Alcohol abuse
  • * Ischaemic heart disease
  • * Unwilling to refrain from drinking grapefruit juice
  • * Currently taking statins
  • * Contraindications to statins (according to the British National Formulary and assessed by taking a history and blood tests at the preliminary visit).
  • * Ingestion of large quantities of grapefruit juice
  • * Participating in another trial or have done so in the last 30 days

Investigators

Sponsor
niversity of Leeds

Similar Trials